Back to search
FDAFDA · Food and drugs·Recall number D-0241-2017

VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30

Published January 4, 2017 · Recall initiated: December 12, 2016

Summary

FDA records drug Class III recall D-0241-2017, published January 4, 2017 and initiated December 12, 2016. Recalling firm: VIRTUS PHARMACEUTICALS OPCO II L; Status: Terminated; Reported quantity: 124,250 bottles; Lot: Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017, 21512164 Exp. date 11/30/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
VIRTUS PHARMACEUTICALS OPCO II L
Distributor
Nationwide
Lot
Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017, 21512164 Exp. date 11/30/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30 recalled?

Yes. FDA published recall D-0241-2017 on January 4, 2017. Reported hazard: cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

What should I do if I have this product?

Voluntary: Firm initiated · Letter